Elder Pharmaceuticals has posted excellent consolidated results for the second quarter ended September 2012. The company's consolidated net profit has gone up to Rs 23.60 crore from the previous year's quarter at Rs 19.35 crore, registering a jump of 22 per cent.
As per the consolidated unaudited provisional results taken on record on November 2, 2012, the income from operations has gone up to Rs 404.06 crore for Q2 FY2013 as compared to Rs 331.08 crore during the corresponding quarter in the previous year.
The consolidated operating profit too has risen to Rs 61.51 crore for Q2 FY2013, reflecting a growth of 12 per cent over the previous corresponding quarter's figure of Rs 54.99 crore.
For the half year ended September 2012, consolidated sales turnover was reported at Rs 757.51 crore (previous half year it was Rs 630.74 crore), up by 20 per cent, while net profit was at Rs 41.64 crore (previous half year Rs 39.46 crore), a jump by 6 per cent.
During the quarter under review, the company launched eight new products across various therapeutic sectors.